Multi-protein Assessment using Serum to deTermine the breast lesion malignancy: a prospective multicenter trial ; MAST trial
Not Applicable
Completed
- Conditions
- Neoplasms
- Registration Number
- KCT0004847
- Lead Sponsor
- Bertis Healthcare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 677
Inclusion Criteria
Patients with lesions of BI-RADS category C4b or higher identified through mammography or ultrasound.
-Women over 19
Patients with no history of other cancers, including breast cancer
Patients who voluntarily decided to participate in this clinical study and signed written informed consent
Patients in BI-RADS category C1-2
Exclusion Criteria
-Patients with recurrent breast cancer
Patients diagnosed with cancer in other organs within 5 years
-Patients with other cancers identified by metastases
-General condition that prevents you from understanding and submitting consent
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity;Specificity
- Secondary Outcome Measures
Name Time Method Predictive values;Positive predictive values;Negative predictive values;Accuracy